Jazz Pharma Plc (JAZZ)
$121.13 1.36 (1.14%)
17:02 EDT JAZZ Stock Quote Delayed 15 Minutes
Previous Close $121.13
Market Cap 7.01B
PE Ratio 16.59
Volume (Avg. Vol.) 344,600
Day's Range 120.00 - 122.17
52-Week Range 113.52 - 165.66
Dividend & Yield N/A (N/A)
JAZZ Stock Predictions, Articles, and Jazz Pharma Plc News
- From InvestorPlace
- From the Web
In this rocky environment, investors should get to know GARP stocks for growth and value. These five stocks offer the best of both worlds.
P/B ratio is a convenient tool to identify low-priced stocks that have high-growth prospects. Here are five stocks with low P/B ratios.
These five biotech stocks balance low valuation with high growth and a track record of profits.
Volatility across all categories of biotech stocks makes this present juncture an ideal time to consider picking up undervalued names.
This week, the ratings of 10 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Jazz Pharmaceuticals stock is hovering around breakeven after agreeing to acquire Celator (CPXX) for a 73% premium. Does the deal make sense?
A bunch of biotech stocks are knocking on the door of news that could prove to be very good or very bad.
While the rest of the market is enjoying a healthy start to the fall, biopharma stocks continue to lag. Here are 5 pharma stocks on sale now
Actavis (ACT) and Jazz Pharmaceuticals (JAZZ) reported outstanding Q3 earnings and are strong biotech stocks to buy.
Can we learn to thrive in the HFT/algo world of high speed trading? Here are some tips and ideas on how to copy in a fast moving market
Two of Jazz Pharmaceuticals' drugs are showing record growth, and the stock just keeps making new highs. Can it last?
These are the 10 fastest-growing companies in the world according to Fortune.
By Jeff Reeves
Investors would be foolish to ignore the massive demographic shift and growth potential that is boosting health care stocks right now.
From Seeking Alpha
Thursday’s Highlights at Noon: Jazz Pharmaceuticals (JAZZ), Amarin (AMRN), Sangamo Biosciences (SGMO), GW Pharma (GWPH), Whiting Petroleum Corp (WLL)
From Analyst Ratings
So far Thursday, October 10, NASDAQ is up 1.9% and the S&P is up 1.84%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Jazz Pharmaceuticals (JAZZ – Research Report), Amarin (AMRN – Research Report), Sangamo Biosciences (SGMO – Research Report), GW Pharma (GWPH – Research Report) and Whiting
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!